Europe Botulinum Toxin Market Size & Outlook, 2023-2030
Europe botulinum toxin market, 2018-2030 (US$M)
Related Markets
Europe botulinum toxin market highlights
- The Europe botulinum toxin market generated a revenue of USD 2,329.0 million in 2023.
- The market is expected to grow at a CAGR of 8.3% from 2024 to 2030.
- In terms of segment, type a was the largest revenue generating product in 2023.
- Type A is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, Germany is expected to register the highest CAGR from 2024 to 2030.
Europe data book summary
| Market revenue in 2023 | USD 2,329.0 million |
| Market revenue in 2030 | USD 4,068.0 million |
| Growth rate | 8.3% (CAGR from 2023 to 2030) |
| Largest segment | Type a |
| Fastest growing segment | Type A |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Type A, Type B |
| Key market players worldwide | Ipsen SA, Merz Pharma, US WorldMeds, Galderma Group AG Registered Shares, Evolus Inc, Allergan, Metabiologics, Lanzhou Institute Of Biological Products |
Other key industry trends
- In terms of revenue, Europe region accounted for 21.0% of the global botulinum toxin market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 4,199.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Botulinum Toxin Market Scope
Botulinum Toxin Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Europe botulinum toxin market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to botulinum toxin market will help companies and investors design strategic landscapes.
Type a was the largest segment with a revenue share of 98.59% in 2023. Horizon Databook has segmented the Europe botulinum toxin market based on type a, type b covering the revenue growth of each sub-segment from 2018 to 2030.
The European botulinum toxin market followed North America in terms of revenue share in 2022 and is expected to maintain its position over the forecast period. The market size is justified by the contribution from developed European economies, such as Germany and the UK, which are major contributors to the Europe BoNT market.
Europe is one of the most advanced regions globally with innovative technologies and well-established infrastructure, resulting in better healthcare facilities & patient care. The region is expected to grow at a lucrative rate over the forecast period due to presence of skilled professionals and rise in the geriatric population.
The rising demand for advanced diagnosis and treatment technologies in Europe is another major factor anticipated to propel the market growth. Furthermore, the relatively less stringent medical device approval process in this region is anticipated to boost market growth.
Reasons to subscribe to Europe botulinum toxin market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Europe botulinum toxin market databook
-
Our clientele includes a mix of botulinum toxin market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe botulinum toxin market , including forecasts for subscribers. This continent databook contains high-level insights into Europe botulinum toxin market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Europe botulinum toxin market size, by country, 2018-2030 (US$M)
Europe Botulinum Toxin Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
